We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

7 hedge funds and large institutions have $845K invested in Alexion Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 693 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

99% less funds holding

Funds holding: 707 → 7 (-700)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 693

100% less funds holding in top 10

Funds holding in top 10: 77 → 0 (-77)

100% less capital invested

Capital invested by funds: $38.8B → $845K (-$38.8B)

Holders
7
Holders Change
-700
Holders Change %
-99.01%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
-77
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
693
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NICM
Neo Ivy Capital Management
New York
+$475K
2
TAIM
TD Ameritrade Investment Management
Nebraska
+$131K
3
RG
Retirement Group
California
+$9.37K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$3.74B
2
BlackRock
BlackRock
New York
-$3.21B
3
State Street
State Street
Massachusetts
-$1.84B
4
FCM
Farallon Capital Management
California
-$1.42B
5
HI
HBK Investments
Texas
-$1.21B
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Capital
201
Walleye Capital
New York
– -$12.2K -66,350 Closed
Nordea Investment Management
202
Nordea Investment Management
Sweden
– -$12.2M -66,189 Closed
RA
203
Ramius Advisors
New York
– -$11.9M -64,655 Closed
TCM
204
Tekla Capital Management
Massachusetts
– -$11.8M -64,453 Closed
BHMP
205
Bardin Hill Management Partners
New York
– -$11.7M -63,707 Closed
AB
206
Amalgamated Bank
New York
– -$11.6M -63,389 Closed
Handelsbanken Fonder
207
Handelsbanken Fonder
Sweden
– -$11.6M -63,235 Closed
MS
208
Maven Securities
Jersey
– -$11.4M -62,000 Closed
ASRS
209
Arizona State Retirement System
Arizona
– -$11.4M -61,897 Closed
Robeco Institutional Asset Management
210
Robeco Institutional Asset Management
Netherlands
– -$11.3M -61,756 Closed
BPGAM
211
BTG Pactual Global Asset Management
Bermuda
– -$11M -59,764 Closed
Envestnet Asset Management
212
Envestnet Asset Management
Illinois
– -$10.9M -59,200 Closed
CM
213
Churchill Management
California
– -$10.7M -58,056 Closed
SOMRS
214
State of Michigan Retirement System
Michigan
– -$10.6M -57,961 Closed
Zurich Cantonal Bank
215
Zurich Cantonal Bank
Switzerland
– -$10.6M -57,727 Closed
JG
216
Jefferies Group
New York
– -$10.6M -57,500 Closed
PA
217
Profund Advisors
Maryland
– -$10.5M -57,295 Closed
BCM
218
BCK Capital Management
Connecticut
– -$10.3M -55,792 Closed
CIBC Asset Management
219
CIBC Asset Management
Ontario, Canada
– -$10.2M -55,296 Closed
HA
220
Havens Advisors
New York
– -$9.92M -54,000 Closed
AssetMark Inc
221
AssetMark Inc
California
– -$9.91M -53,936 Closed
Caisse de Depot et Placement du Quebec (CDPQ)
222
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
– -$9.83M -53,525 Closed
EAM
223
Erste Asset Management
Austria
– -$9.77M -53,000 Closed
BFM
224
Boothbay Fund Management
New York
– -$9.61M -52,296 Closed
FAF
225
Första AP-fonden
Sweden
– -$9.52M -51,800 Closed
7 8
9
10 11

ALXN Hedge Fund Activity: Q3 2021 in Review

7 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q3 2021, worth a combined $845K — down 100% from $38.8B a quarter earlier.

Sellers outnumbered buyers: 693 funds closed out of ALXN and 1 opened new positions — a net loss of 692 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Neo Ivy Capital Management, opening a new position worth an estimated $475K. The largest seller was Vanguard Group, exiting entirely with an estimated $3.74B sold.

  • 7 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q3 2021, down from 707 in Q2 2021.
  • Funds reported $845K of Alexion Pharmaceuticals stock for Q3 2021, down 100% quarter-over-quarter.
  • 1 fund opened new Alexion Pharmaceuticals positions in Q3 2021 and 693 closed out, a net change of -692 holders.
  • The largest Alexion Pharmaceuticals buyer in Q3 2021 was Neo Ivy Capital Management, an estimated $475K added.
  • The largest Alexion Pharmaceuticals seller in Q3 2021 was Vanguard Group, an estimated $3.74B sold.

Based on aggregated 13F filings for Q3 2021.